Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Ask the Doctor Question: I think it was on the CLL Society site that I read that IV chemo is NOT the current recommendation for initial CLL treatment. Am I remembering correctly? Answer: Yes, you are absolutely correct. There are some
The phase III Alliance A041202 collaborative multi-centered trial demonstrated once and for all the superiority of ibrutinib versus Bendamustine/Rituximab (BR) when used frontline in older CLL patients. Dr. Brander from Duke fills in more details at iwCLL 2019 in Scotland.
When CNN has a headline that Chemo-free drug combo shows ‘dramatic’ improvement against common leukemia in adults and reports on a medical journal article on a rare disease such as CLL that’s big news, isn’t it? When New England Journal
By Brian Koffman, MD This is really big news. Practice changing news. Dr. Jennifer Woyach of Ohio State presented the results of the large phase III Alliance A041202 collaborative multi-centered trial that was designed to see if we should change how
One click to our most popular content.
